| # | Side effect | Count |
|---|---|---|
| 0 | OFF LABEL USE | 171 |
| 1 | DEATH | 162 |
| 2 | NEOPLASM PROGRESSION | 82 |
| 3 | FATIGUE | 68 |
| 4 | WEIGHT DECREASED | 47 |
| 5 | HYPERTENSION | 46 |
| 6 | BLOOD PRESSURE INCREASED | 44 |
| 7 | WEIGHT INCREASED | 37 |
| 8 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 32 |
| 9 | MALAISE | 32 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | BODY SURFACE AREA DECREASED | 2 | 0.0247 |
| 1 | IMMATURE GRANULOCYTE COUNT INCREASED | 5 | 0.0177 |
| 2 | ADNEXA UTERI MASS | 3 | 0.0104 |
| 3 | WHITE COAT HYPERTENSION | 3 | 0.0055 |
| 4 | GRANULOCYTE COUNT INCREASED | 2 | 0.0049 |
| 5 | MEAN CELL HAEMOGLOBIN INCREASED | 7 | 0.0042 |
| 6 | MONOCYTE COUNT DECREASED | 5 | 0.0041 |
| 7 | GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE | 2 | 0.0038 |
| 8 | MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED | 2 | 0.0036 |
| 9 | BLOOD PRESSURE DIASTOLIC INCREASED | 16 | 0.0035 |